Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Senseer is a medical technology company developing a multi-modal sensing platform designed to improve the management of chronic conditions requiring implantable devices. The company's primary focus is on hydrocephalus, where it has developed a "smart" shunt system capable of monitoring intracranial pressure and cerebrospinal fluid flow in real-time. By providing clinicians with actionable data, Senseer aims to reduce the high failure rates and frequent revisions associated with traditional shunt systems. The technology originated from research at the University of Southern California and is being expanded to other applications such as traumatic brain injury and cardiovascular monitoring. Senseer's platform utilizes micro-electromechanical systems (MEMS) to provide long-term, reliable monitoring within the body.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Senseer.